Physician profile
Jonathan Pollack
NPI 1972572360
$1,262.06
in general payments reported to CMS, 2019-2025
22 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $199 · 2021: $156 · 2022: $44.41 · 2023: $116 · 2024: $162 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $181.71 | 2023-2025 | Recell, Permeaderm, Cohealyx |
| Allergan, INC. | $178.57 | 2019-2022 | |
| Rti Surgical, INC | $130.14 | 2021 | |
| Integra Lifesciences Corporation | $115.44 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $83.44 | 2019-2025 | Collagenase Santyl, Oasis |
| Depuy Synthes Sales INC. | $83.37 | 2020 | |
| Acera Surgical, INC. | $56.46 | 2019 | |
| Axogen | $55.69 | 2019 | |
| Abbvie INC. | $44.94 | 2023-2024 | |
| Endo Pharmaceuticals INC. | $39.07 | 2019 | |
| Acell, INC. | $35.18 | 2019 | |
| Polarityte, INC. | $33.73 | 2019 | |
| Polynovo North America LLC | $30.62 | 2024 | Novosorb Btm |
| Solventum Corporation | $28.73 | 2024 | Activ.A.C. |
| Endo USA, INC. | $27.99 | 2025 | Xiaflex |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tei Medical INC. | $26.74 | 2019 | |
| Vericel Corporation | $23.26 | 2025 | |
| Derma Sciences, INC. | $20.22 | 2019 | |
| Elite Orthopedics, LLC | $19.90 | 2019 | |
| Medline Industries LP | $18.16 | 2019 | |
| Kerecis Limited | $17.08 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Triad Life Sciences INC. | $11.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Pollack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.